Norwest Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 06-07-2024
- Paid Up Capital ₹ 1.12 M
as on 06-07-2024
- Company Age 40 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -45.21%
(FY 2022)
- Profit 58.69%
(FY 2022)
- Ebitda 75.71%
(FY 2022)
- Net Worth -46.76%
(FY 2022)
- Total Assets -6.26%
(FY 2022)
About Norwest Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.12 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Sawhney and Sandhya Sawhney serve as directors at the Company.
- CIN/LLPIN
U74899DL1984PTC018048
- Company No.
018048
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 1984
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Norwest Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Sawhney  | Additional Director | 30-Sep-2022 | Current |
| Sandhya Sawhney | Director | 16-Aug-2010 | Current |
Financial Performance and Corporate Structure Insights of Norwest Pharmaceuticals.
Norwest Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 45.21% decrease. The company also saw a substantial improvement in profitability, with a 58.69% increase in profit. The company's net worth observed a substantial decline by a decrease of 46.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Norwest Pharmaceuticals?
In 2022, Norwest Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tersus Technology Solutions Llp
Active 8 years 14 daysNitin Sawhney and Sandhya Sawhney are mutual person
Orangutan Technologies Private Limited
Active 1 year 3 monthsNitin Sawhney and Sandhya Sawhney are mutual person
Tippytrip Travel Technologies Private Limited
Active 11 months 6 daysSandhya Sawhney is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Norwest Pharmaceuticals?
Unlock and access historical data on people associated with Norwest Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Norwest Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Norwest Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
